2014

Purdue Pharma L.P. Presents Data from Research Studies at American Pain Society 33rd Annual Scientific Meeting

STAMFORD, Conn., April 29, 2014 /PRNewswire/ -- Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33rd Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla.

Following is a schedule of select poster presentations:


 

Title

Authors

Date / Time

A Single-Center, Randomized, Double-Blind

Crossover Study to Evaluate the Abuse

Potential, Pharmacokinetics, and Safety of

Milled and Intranasally Administered Extended-

Release Hydrocodone in Recreational Opioid

Users

Harris S, Colucci S, Perrino P,  Kapil R, Geoffroy P, Hopyan T,  Levy-Cooperman N

Thursday, May 1

9:30 AM–11:00 AM

A Single-Center, Randomized, Double-Blind,

Crossover Study to Evaluate the Abuse

Potential, Pharmacokinetics, and Safety of Oral

Milled and Intact Extended-Release

Hydrocodone (HYD) Tablets in Recreational

Opioid Users

Harris S, Colucci S, Perrino P,  Kapil R, Geoffroy P, Hopyan T,  Levy-Cooperman N

Friday, May 2

8:45 AM-10:15 AM

 

Long-term Safety and Effectiveness of Once-

daily, Single-entity, Abuse-deterrent

Hydrocodone in Chronic Nonmalignant and

Nonneuropathic Pain: Results of a Long-term

Open-label Study

Wen W, Taber L, Lynch SY, Munera C, Ripa SR

Thursday, May 1

9:30 AM–11:00 AM

In Vitro Assessment of the Effects of Alcohol on

the Release Rate of Hydrocodone Bitartrate

from a Once-daily, Single-Entity, Hydrocodone

Bitartrate Formulation

Giordano J, Huang H, Kianto J

Friday, May 2

8:45 AM-10:15 AM

 

Comparison of the Risk of Opioid Overdose

among Patients Prescribed Immediate-Release

and Extended-Release Opioid Analgesics

Coplan P, DeVeaugh-Geiss A, Kadakia A

Thursday, May 1

9:30 AM–11:00 AM

Abuse-deterrent Opioid Analgesic

Formulations: Technology, Evaluation, and

Labeling

Haddox D

Friday, May 2, 2014

8:45 AM - 10:15 AM

 

Impact of an opioid reformulation with abuse-

deterrent properties on doctor-shopping

Chilcoat H, Coplan PM, Sessler NE, Schultz Y, Yuan Y

Friday, May 2, 2014

8:45 AM - 10:15 AM

Epidemiology of Conditions Associated with

Pain and the Use of Analgesic and Non-

Analgesic Treatments in Pediatrics

Wallace L, Baldridge S,  Matsuno R

Thursday, May 1

9:30 AM – 11:00 AM

Neonatal Abstinence Syndrome in

Commercially-insured and Medicaid Patients:

Differences in Patient and Maternal

Characteristics and Outpatient Treatment

Patterns

Wallace L, Harding B, Matsuno RK

 

Thursday, May 1,

9:30 AM – 11:00 AM


About Purdue Pharma L.P.

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.



Contact: 


James Heins

Jennifer Soares

Senior Director, Public Affairs

Senior Manager, Corporate Affairs & Communications

office: 203-588-8069

office: 203-588-7623

mobile: 203-856-2121

mobile: 203-609-1746

Email: james.heins@pharma.com

email: jennifer.soares@pharma.com

 

SOURCE Purdue Pharma L.P.



RELATED LINKS
http://www.purduepharma.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.